A recent article by Goldstein and his associates (Circulation 43: 629, 1971) misquoted studies from our laboratory as failing to demonstrate any improvement following oral isosorbide dinitrate (ISD).' In fact, our studies indicated the therapeutic efficacy of ISD. We would like to correct the Goldstein statement and comment about other aspects of drug evaluation in angina as discussed by Redwood and his associates (Circulation 43: 618, 1971).
Isosorbide Dinitrate in Angina
To the Editor:
A recent article by Goldstein and his associates (Circulation 43: 629, 1971) misquoted studies from our laboratory as failing to demonstrate any improvement following oral isosorbide dinitrate (ISD).' In fact, our studies indicated the therapeutic efficacy of ISD. We would like to correct the Goldstein statement and comment about other aspects of drug evaluation in angina as discussed by Redwood and his associates (Circulation 43: 618, 1971) .
We agree that efficacy may be difficult to demonstrate if the work load is too high and duration of exercise too short. The authors felt that angina should occur between 3 and 6 min using the bicycle ergometer, as lower work loads were associated with increased test time and fatigue. However, our treadmill studies starting at 1.2 mph and 10% grade with 0.6 mph increments every 3 min indicated no fatigue at 9 min in all but one patient, with significant angina occurring during placebo administration between 6 and 9 min.1 This difference in end point may indicate that the treadmill test provides a more physiologic type of stress when low work loads are employed.
The traditional use of time per se, regardless of increasing work loads, as a measurement of drug effectiveness may be misleading. We evaluate exercise performance (EP) as summation of speed X time or, in the case of the bicycle, summation of watts X time, thus giving more credit for the increased wrok that a patient performs during incremental exercise. For example, walking 3 min at 2.4 mph gives an EP of 7.2 compared to a value of 5.4 for walking 3 min at 1.8 mph.
Goldstein and associates eloquently showed that the triple product, utilizing aortic pressure, is the best indirect determinant of oxygen consumption. However, the use of the pressure-rate index, with indirect blood pressure determinations, should not be completely disregarded as it is practical and useful when each patient serves as his own control.
Our studies provided evidence that oral ISD is effective in partially alleviating angina, and we have previously discussed the current controversy Circulation, Volume XLIV, December 1971 over the efficacy of this drug.2 Our data on 10 patients may be summarized as follows ( fig. 1) : EP increased at 1+ pain from 10.4 on placebo to 12.8, 13.1, and 15.0 mph-min on propranolol, ISD, and the combination, respectively; at 3+ pain from 17.9 to 21.3, 21.7, and 22.5 mph-min, respectively (P <0.05). This corresponded to a relative increase in EP at 1+ pain of 32, 45, and 75%, and at 3+ pain of 36, 48, and 62%, respectively. There was no statistical difference between drug therapies although the combination effected a greater overall clinical improvement. There was no change in pressure-rate index on ISD alone as opposed to about a 30% decrease on propranolol and the combination.
Finally, our patients were tested 2 hr after oral ISD treatment, and a favorable response was evoked in seven of the patients, as compared to the ineffectiveness of sublingual ISD at 2 hr in the present studies. Also, one patient, studied after 4 months of ISD (15 mg q.i.d.), had a marked improvement in EP at 4 hr, which further supports the longer duration of action of oral ISD and suggests the absence of tachyphylaxis to ISD.
